Century Therapeutics, Inc. Annual Depreciation in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Century Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2023.
  • Century Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $3.46M, a 7.05% increase year-over-year.
  • Century Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $13.6M, a 15.6% increase year-over-year.
  • Century Therapeutics, Inc. annual Depreciation for 2023 was $13M, a 54.6% increase from 2022.
  • Century Therapeutics, Inc. annual Depreciation for 2022 was $8.44M, a 125% increase from 2021.
  • Century Therapeutics, Inc. annual Depreciation for 2021 was $3.75M, a 167% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $13M +$4.6M +54.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $8.44M +$4.69M +125% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $3.75M +$2.35M +167% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $1.4M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.